Bowdin Sarah, Allen Cathy, Kirby Gail, Brueton Louise, Afnan Masoud, Barratt Christopher, Kirkman-Brown Jackson, Harrison Robert, Maher Eamonn R, Reardon William
Clinical Genetics Unit, Birmingham Women's Hospital, Edgbaston, Birmingham, UK.
Hum Reprod. 2007 Dec;22(12):3237-40. doi: 10.1093/humrep/dem268. Epub 2007 Oct 5.
Genomic imprinting is an epigenetic process in which allele-specific gene expression is dependent on the parental inheritance. Although only a minority of human genes are imprinted, those that have been identified to date have been preferentially implicated in prenatal growth and neurodevelopment. Mutations or epimutations in imprinted genes or imprinting control centres are associated with imprinting disorders such as Angelman syndrome (AS) and Beckwith-Wiedemann syndrome (BWS). Recently, an increased frequency of assisted reproductive technology (ART) conceptions has been reported in children with BWS and AS. However, the risk of imprinting disorders in ART children is unknown.
We undertook a survey of 2492 children born after ART in the Republic of Ireland and Central England with the aim of detecting cases (both clinically diagnosed and previously unrecognized) of BWS and AS in this cohort. The response rate to an initial questionnaire was 61%, corresponding to data for 1524 children. After evaluation of the questionnaire, 70 children were invited for a detailed clinical assessment, and 47 accepted (response rate of 67%).
In this entire cohort, we detected one case of BWS and no cases of AS. We did not find evidence that there exists a significant group of ART children with unrecognized milder forms of AS or BWS.
Although previous studies have suggested an increased relative risk of BWS and AS after ART, our findings suggest that the absolute risk of imprinting disorders in children conceived by ART is small (<1%). Precise risk estimates of risk are difficult to define because of the rarity of the conditions and incomplete response rates to the questionnaire and clinical examination invitations. Hence further investigations are indicated to (i) refine the absolute and relative risks of imprinting disorders after ART and (ii) ensure that changes in ART protocols are not associated with increased frequencies of epigenetic changes and imprinting disorders in children born after ART.
基因组印记是一种表观遗传过程,其中等位基因特异性基因表达取决于亲本遗传。虽然只有少数人类基因是印记基因,但迄今为止已鉴定出的那些基因优先参与产前生长和神经发育。印记基因或印记控制中心的突变或表观突变与诸如天使综合征(AS)和贝克威思-维德曼综合征(BWS)等印记障碍相关。最近,有报道称BWS和AS患儿中辅助生殖技术(ART)受孕的频率增加。然而,ART儿童患印记障碍的风险尚不清楚。
我们对爱尔兰共和国和英格兰中部ART后出生的2492名儿童进行了一项调查,目的是在该队列中检测BWS和AS病例(包括临床诊断的和以前未识别的)。对初始问卷的回复率为61%,对应1524名儿童的数据。在对问卷进行评估后,邀请70名儿童进行详细的临床评估,47名儿童接受邀请(回复率为67%)。
在整个队列中,我们检测到1例BWS,未检测到AS病例。我们没有发现证据表明存在大量未被识别的轻度AS或BWS形式的ART儿童。
虽然先前的研究表明ART后BWS和AS的相对风险增加,但我们的研究结果表明,ART受孕儿童患印记障碍的绝对风险很小(<1%)。由于这些疾病罕见,以及对问卷和临床检查邀请的回复率不完整,因此难以确定精确的风险估计值。因此,需要进一步调查以(i)完善ART后印记障碍的绝对和相对风险,以及(ii)确保ART方案的改变与ART后出生儿童表观遗传变化和印记障碍频率的增加无关。